Updated Apr. 2, 2013 at 7:03 a.m.

Premium Lock BioCryst shares rally on possibility of keeping $235M influenza project alive

Published: 2013-04-01 08:14:00
Updated: 2013-04-02 07:03:58

BioCryst BioCryst

BioCryst, which cut half its work force in a cost-cutting move in December, says it will meet with the FDA to dermine ways it might advance the intravenous flue treatment peramivir alive....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders